China Foods Holdings Ltd.

CFOO ·Healthcare, Drug Manufacturers - General, Hong Kong
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-398.7K $-455.6K $-403.7K $-354.1K $-455.4K $-469.5K $82.8K $-62.8K
Depreciation & Amortization — — — — — — — —
Depreciation $7.0K $1.8K $42.4K $65.2K $91.0K $71.5K $38.0K —
Amortization $469 $467 $433 $500 $521 $487 $208 —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-389.3K $-353.8K $-316.9K $-171.6K $-438.6K $343.7K $706.0K $-35.1K
Investing Activities
Capital Expenditures — $23.5K $746 — $27.4K $75.1K $120.6K —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — $-23.5K $-746 $22.9K $-27.4K $-67.9K $-123.9K $0
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $388.6K $245.5K $114.3K $-52.7K $50.3K $45.9K $19.4K $20.0K
Net Change in Cash $-29.3K $-135.7K $-206.8K $-227.7K $-397.0K $371.9K $584.1K $-15.1K
Free Cash Flow — $-377.3K $-317.7K — $-466.0K $268.6K $585.4K —
← Newer Page 1 of 2 Older →